Futura Medical (LON:FUM) Shares Cross Below Fifty Day Moving Average – Here’s What Happened

Futura Medical plc (LON:FUM)’s share price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 1.66 and traded as low as GBX 1.08. Futura Medical shares last traded at GBX 1.10, with a volume of 7,715,260 shares changing hands.

Futura Medical Price Performance

The business has a 50 day simple moving average of GBX 1.66 and a 200 day simple moving average of GBX 5.92. The company has a market capitalization of £3.80 million, a price-to-earnings ratio of -0.54 and a beta of 1.25.

Futura Medical (LON:FUM) last issued its quarterly earnings data on Tuesday, September 30th. The company reported GBX (2.17) earnings per share for the quarter. Futura Medical had a negative net margin of 44.64% and a negative return on equity of 56.44%. On average, equities research analysts predict that Futura Medical plc will post 2.8486672 EPS for the current year.

Insiders Place Their Bets

In other Futura Medical news, insider Harmesh Suniara sold 4,441,678 shares of Futura Medical stock in a transaction dated Thursday, November 13th. The stock was sold at an average price of GBX 2, for a total value of £88,833.56. 25.86% of the stock is currently owned by corporate insiders.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.